Large-vessel vasculitis

D Pugh, M Karabayas, N Basu, MC Cid… - Nature Reviews …, 2021 - nature.com
Large-vessel vasculitis (LVV) manifests as inflammation of the aorta and its major branches
and is the most common primary vasculitis in adults. LVV comprises two distinct conditions …

Glucocorticoids—all-rounders tackling the versatile players of the immune system

C Strehl, L Ehlers, T Gaber, F Buttgereit - Frontiers in immunology, 2019 - frontiersin.org
Glucocorticoids regulate fundamental processes of the human body and control cellular
functions such as cell metabolism, growth, differentiation, and apoptosis. Moreover …

Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the …

Y Nakaoka, M Isobe, S Takei, Y Tanaka… - Annals of the …, 2018 - ard.bmj.com
Objective To investigate the efficacy and safety of the interleukin-6 receptor antibody
tocilizumab in patients with Takayasu arteritis (TAK). Methods Patients with TAK who had …

Pathogenesis of giant cell arteritis and Takayasu arteritis—similarities and differences

R Watanabe, GJ Berry, DH Liang, JJ Goronzy… - Current rheumatology …, 2020 - Springer
Abstract Purpose of Review Giant cell arteritis (GCA) and Takayasu arteritis (TAK) are auto-
inflammatory and autoimmune diseases with a highly selective tissue tropism for medium …

Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis—a systematic review and meta-analysis

DP Misra, U Rathore, P Patro, V Agarwal… - Clinical Rheumatology, 2021 - Springer
The pharmacotherapy of Takayasu arteritis (TAK) with disease-modifying anti-rheumatic
drugs (DMARDs) is an evolving area. A systematic review of Scopus, Web of Science …

Takayasu arteritis

RAG Russo, MM Katsicas - Frontiers in pediatrics, 2018 - frontiersin.org
Takayasu arteritis is an idiopathic granulomatous vasculitis of the aorta and its main
branches and it constitutes one of the more common vasculitides in children. Inflammation …

Takayasu arteritis: advanced understanding is leading to new horizons

E Tombetti, JC Mason - Rheumatology, 2019 - academic.oup.com
Although outcomes in Takayasu arteritis (TAK) are improving, diagnosis is typically delayed
and significant arterial injury accrues. While wider use of non-invasive imaging is impacting …

Comparative efficacy of secukinumab versus tumor necrosis factor inhibitors for the treatment of Takayasu arteritis

X Tian, M Li, N Jiang, Y Zhao, J Li, Y Zhou… - Arthritis & …, 2023 - Wiley Online Library
Objective Tumor necrosis factor (TNF) alpha and interleukin‐17 (IL‐17) are thought to be
involved in the pathogenesis of Takayasu arteritis (TAK), and TNF inhibitors (TNFi) are …

Age as a risk factor in vasculitis

AD Gloor, GJ Berry, JJ Goronzy… - Seminars in …, 2022 - Springer
Two vasculitides, giant cell arteritis (GCA) and Takayasu arteritis (TAK), are recognized as
autoimmune and autoinflammatory diseases that manifest exclusively within the aorta and …

Innate and adaptive immunity in giant cell arteritis

M Akiyama, S Ohtsuki, GJ Berry, DH Liang… - Frontiers in …, 2021 - frontiersin.org
Autoimmune diseases can afflict every organ system, including blood vessels that are
critically important for host survival. The most frequent autoimmune vasculitis is giant cell …